Affiliate Press Releases | Back to
ALS page
2004
First Biomarkers to Diagnose Lou Gehrig's Disease Found in CNS.
A University of Pittsburgh pathologist, along with Harvard co-authors, has identified the first protein biomarkers able to diagnose
patients with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease) with near 100 percent accuracy.
April 2004
2003
Combination therapy shows promise for delaying progression of Lou Gherig's disease.
New cocktail of minocycline and creatine may extend survival by 25 percent.
January 2003
2002
Researchers detail how antibiotic minocycline delays progression of Lou Gherigís disease
.
Researchers have identified the process in which the antibiotic, minocycline, inhibits the progression of cell death in the
brain that causes amyotrophic lateral sclerosis (ALS).
May 2002
Research shines light on Parkinson's and other brain disorders.
Stem cell research shows promise for creation of
nerve cells that conduct dopamine, which will help in efforts to address illnesses like Parkinson's
and ALS. December 2002
2001
New Center Will Bring Basic Neuroscience to the Bedside.
The Harvard Center for Neurodegeneration
and Repair (HCNR).
February 2001
2000
Researchers Identify Possible Pathway that May Slow the Progression
of Lou Gehrig's Disease - Finding May Lead to New Drug Therapies
Women who have diabetes have a substantially greater risk of dying a few years after suffering
a heart attack than do non-diabetic women. April 2000
|
